231 related articles for article (PubMed ID: 2833185)
41. Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology.
Volck B; Johansen JS; Stoltenberg M; Garbarsch C; Price PA; Ostergaard M; Ostergaard K; Løvgreen-Nielsen P; Sonne-Holm S; Lorenzen I
Osteoarthritis Cartilage; 2001 Apr; 9(3):203-14. PubMed ID: 11300743
[TBL] [Abstract][Full Text] [Related]
42. The complement system is activated in synovial fluid from subjects with knee injury and from patients with osteoarthritis.
Struglics A; Okroj M; Swärd P; Frobell R; Saxne T; Lohmander LS; Blom AM
Arthritis Res Ther; 2016 Oct; 18(1):223. PubMed ID: 27716448
[TBL] [Abstract][Full Text] [Related]
43. Comparative analysis of CD45RA- and CD45RO-positive CD4+T cells in peripheral blood, synovial fluid, and synovial tissue in patients with rheumatoid arthritis and osteoarthritis.
Ezawa K; Yamamura M; Matsui H; Ota Z; Makino H
Acta Med Okayama; 1997 Feb; 51(1):25-31. PubMed ID: 9057932
[TBL] [Abstract][Full Text] [Related]
44. C1 activation, with C1q in excess of functional C1 in synovial fluid from patients with rheumatoid arthritis.
Sjöholm AG; Berglund K; Johnson U; Laurell AB; Sturfelt G
Int Arch Allergy Appl Immunol; 1986; 79(2):113-9. PubMed ID: 3484727
[TBL] [Abstract][Full Text] [Related]
45. Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies.
Bedwell AE; Elson CJ; Carter SD; Dieppe PA; Hutton CW; Czudek R
Ann Rheum Dis; 1987 Jan; 46(1):55-64. PubMed ID: 3492971
[TBL] [Abstract][Full Text] [Related]
46. Autoantibodies to glucose-6-phosphate isomerase are elevated in the synovial fluid of rheumatoid arthritis patients.
Cha HS; Kim TJ; Kim JY; Lee MH; Jeon CH; Kim J; Bae EK; Ahn KS; Koh EM
Scand J Rheumatol; 2004; 33(3):179-84. PubMed ID: 15228189
[TBL] [Abstract][Full Text] [Related]
47. Complement and immunoglobulins in synovial fluid from synovectomized patients with rheumatoid arthritis.
Mellbye OJ; Naes B; Munthe E
Ann Rheum Dis; 1976 Jun; 35(3):233-9. PubMed ID: 825053
[TBL] [Abstract][Full Text] [Related]
48. An analysis of the levels of complement components in the synovial fluid in rheumatic diseases.
Swaak AJ; Van Rooyen A; Planten O; Han H; Hattink O; Hack E
Clin Rheumatol; 1987 Sep; 6(3):350-7. PubMed ID: 3442962
[TBL] [Abstract][Full Text] [Related]
49. Anti-cyclic citrullinated peptide antibody determination in synovial fluid of psoriatic arthritis.
Spadaro A; Riccieri V; Scrivo R; Alessandri C; Valesini G
Clin Exp Rheumatol; 2007; 25(4):599-604. PubMed ID: 17888217
[TBL] [Abstract][Full Text] [Related]
50. Differences in serum and synovial CD4+ T cells and cytokine profiles to stratify patients with inflammatory osteoarthritis and rheumatoid arthritis.
Penatti A; Facciotti F; De Matteis R; Larghi P; Paroni M; Murgo A; De Lucia O; Pagani M; Pierannunzii L; Truzzi M; Ioan-Facsinay A; Abrignani S; Geginat J; Meroni PL
Arthritis Res Ther; 2017 May; 19(1):103. PubMed ID: 28526072
[TBL] [Abstract][Full Text] [Related]
51. Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals.
Biró E; Nieuwland R; Tak PP; Pronk LM; Schaap MC; Sturk A; Hack CE
Ann Rheum Dis; 2007 Aug; 66(8):1085-92. PubMed ID: 17261534
[TBL] [Abstract][Full Text] [Related]
52. Tryptophan catabolism in synovial fluid of various arthropathies and its relationship with inflammatory cytokines.
Bertazzo A; Punzi L; Bertazzolo N; Pianon M; Pozzuoli A; Costa CV; Allegri G
Adv Exp Med Biol; 1999; 467():565-70. PubMed ID: 10721101
[TBL] [Abstract][Full Text] [Related]
53. Interleukin 13 in synovial fluid and serum of patients with psoriatic arthritis.
Spadaro A; Rinaldi T; Riccieri V; Valesini G; Taccari E
Ann Rheum Dis; 2002 Feb; 61(2):174-6. PubMed ID: 11796407
[TBL] [Abstract][Full Text] [Related]
54. Rheumatoid arthritis synovial fluid fibroblasts express TRAIL-R2 (DR5) that is functionally active.
Miranda-Carús ME; Balsa A; Benito-Miguel M; De Ayala CP; Martín-Mola E
Arthritis Rheum; 2004 Sep; 50(9):2786-93. PubMed ID: 15457446
[TBL] [Abstract][Full Text] [Related]
55. Immunopathological changes in rheumatoid arthritis and other joint diseases.
Ghose T; Woodbury JF; Ahmad S; Stevenson B
J Clin Pathol; 1975 Feb; 28(2):109-17. PubMed ID: 1092716
[TBL] [Abstract][Full Text] [Related]
56. Measurement of sulphated glycosaminoglycans and proteoglycan fragments in arthritic synovial fluid.
Carroll G
Ann Rheum Dis; 1989 Jan; 48(1):17-24. PubMed ID: 2923503
[TBL] [Abstract][Full Text] [Related]
57. [Activated C3 in the synovial fluid of patients with rheumatoid arthritis and arthrosis (correlations with C3, C4 and C3 proactivator/modification caused by storage)].
Hasler F; Stojan B
Z Rheumatol; 1981; 40(1):40-3. PubMed ID: 6908792
[TBL] [Abstract][Full Text] [Related]
58. Depressed synovial fluid levels of properdin and properdin factor B in patients with rheumatoid arthritis.
Ruddy S; Fearon DT; Austen KF
Arthritis Rheum; 1975; 18(4):289-95. PubMed ID: 808229
[TBL] [Abstract][Full Text] [Related]
59. Interferon in synovial fluid and serum of patients with rheumatic disease.
Cesario TC; Andrews BS; Martin DA; Jason M; Treadwell T; Friou G; Tilles JG
J Rheumatol; 1983 Aug; 10(4):647-50. PubMed ID: 6194296
[TBL] [Abstract][Full Text] [Related]
60. Behaviour of synovial complement C3 and C4 components in inflammatory and degenerative joint diseases, before and after synoviorthesis.
Gabay R; Micheli A; Fallet GH
Ann Rheum Dis; 1975 Apr; 34(2):166-70. PubMed ID: 806271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
